Certain Series B-3 Convertible Preferred Stock of Forma Therapeutics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 16-DEC-2020. These Series B-3 Convertible Preferred Stock will be under lockup for 181 days starting from 18-JUN-2020 to 16-DEC-2020. Details: The company directors, executive officers and holders of substantially all of its outstanding shares of common stock, or securities convertible into or exchangeable for shares of its common stock have agreed that, for a period of 180 days from the date of this prospectus, they will not, without the prior written consent of SVB Leerink LLC, Credit Suisse Securities (USA) LLC and Jefferies LLC, dispose of any shares or any securities convertible into or exchangeable for its common stock.